4//SEC Filing
Zarrabian Saiid 4
Accession 0001213900-17-011531
CIK 0001498382other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 8:10 PM ET
Size
5.3 KB
Accession
0001213900-17-011531
Insider Transaction Report
Form 4
Zarrabian Saiid
DirectorInterim CEO
Transactions
- Award
Options (Right to Buy)
2017-11-03+120,000→ 120,000 totalExercise: $0.87Exp: 2027-11-03→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the first anniversary of the date of grant.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001495521
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 8:10 PM ET
- Size
- 5.3 KB